RE:covidReturning to COVID is not the way forward. The company should keep its main focus on AI, which has a more long-term perspective. Analytics is a scalable platform, Nexa can still secure those contracts, and EV can continue to generate marginal revenues. Reverting to COVID kits should not be the path forward; instead, they just need to replicate the success of the kits with AI.